Summary
In a child lacking adenosine deaminase and in patients treated with deoxycoformycin (a potent inhibitor of the enzyme), apparent renal secretion of 2′-deoxyadenosine (dAdo) and reabsorption of adenosine (Ado) were observed. The renal clearance of dAdo in humans was approximately five-fold that of creatinine, whereas the renal clearance of Ado was only one-fifth that of creatinine. In mice treated with deoxycoformycin, a similar paradigm was observed. Specifically, plasma levels of Ado and dAdo were elevated to detectable levels and apparent renal secretion and reabsorption of these purine nucleosides became manifest. Thus, the mouse may serve as a suitable model to study the renal handling of these two compounds. The active renal secretion of dAdo may occur because the compound has not been appreciably synthesized by mouse kidney in situ, and ‘ion-trapping’ of dAdo in acid urine could not explain the net secretion. The differential transport of these similar purine nucleosides suggests a very selective transport system in mammalian kidney. Although carrier-mediated, facilitated diffusion of purine nucleosides across cell membranes is a well-known phenomenon, the present data indicate the existence of (an) active transport sysem(s) for the transepithelial secretion of dAdo, and possibly for the reabsorption of Ado.
Similar content being viewed by others
Abbreviations
- ADA:
-
adenosine aminohydrolase EC 3.5.4.4
- Ado:
-
adenosine
- dAdo:
-
2′-deoxyadenosine
- DCF:
-
2′-deoxycoformycin
- HPLC:
-
high-performance liquid chromatography
- PBS:
-
0.14 M NaCl plus 0.01 M phosphate buffer, pH 7.4
- PNPase:
-
purine nucleoside: orthophosphate ribosyltransferase EC 2.4.2.1
- SCID: ADA- :
-
severe combined immunodeficiency disease associated with ADA deficiency
References
Agarwal RP, Spector T, Parks RE Jr (1977) Tight-binding inhibitors IV. Inhibition of adenosine deaminases by various inhibitors. Biochem Pharmacol 26: 359–367
Benjamin RS, Plunkett W, Keating ML, Feun LG, Hug J, Nelson JA, Bodey GP, Freireich EJ (1980) Phase I and biochemical pharmacological studies of deoxycoformycin. (Abstract) Proc Am Soc Clin Oncol 21: 337
Bloch A (ed) (1975) Chemistry, biology, and clinical uses of nucleoside analogs. Ann NY Acad Sci 255 [Whole volume]
Donofrio J, Coleman MS, Hutton JJ, Daoud A (1978) Over-production of adenine deoxyribonucleosides and deoxyribonucleotides in adenosine deaminase deficiency with severe combined immunodeficiency disease. J Clin Invest 62: 884–887
Fasman GD (ed) (1975) Handbook of biochemistry and molecular biology, 3rd edn, vol I: Nucleic acids. CRC Press, Cleveland, p 141
Hartwick RA, Brown PR (1976) Evaluation of microparticle chemically bonded reversed-phase packings in the high pressure liquid chromatographic analysis of nucleosides and their bases. J Chromatogr 126: 679–691
Hirschhorn R, Roegner V, Rubinstein A, Papgeorgiou P (1980) Plasma deoxyadenosine, adenosine and deoxy ATP are elevated at birth in an adenosine deaminase-deficient child. J Clin Invest 65: 768–771
Kennedy WP (1961) Creatine, creatinine, and total body potassium in relation to muscle mass in children. Arch Dis Child 36: 325–327
Konikowski T, Haynie TP, Farr LE (1970) Inulin clearance in mice as a standard for radiopharmaceutical bioassy. Proc Soc Exp Biol Med 135: 320–324
Kuttesch JF, Schmalstieg FC, Nelson JA (1978) Analysis of adenosine and other adenine compounds in patients with immunodeficiency disease. Journal of Liquid Chromatography 1: 97–109
Kuttesch JF, Robins MJ, Nelson JA (1980a) Active transport of a deoxyribonucleoside by mammalian kidney. (Abstract) Proc Am Assoc Cancer Res 21: 133
Kuttesch JF, Robins MJ, Nelson JA (1980b) Active transport of deoxyribonucleosides by mammalian kidney. (Abstract) Pharmacologist 22: 238
Meuwissen JH, Pollara B, Pickering RJ, Porter IH (eds) (1975) Combined immunodeficiency disease and adenosine deaminase deficiency. Academic Press, New York
Mills GC, Schmalstieg FC, Trimmer KB, Goldman AS, Goldblum RM (1976) Purine metabolism in adenosine deaminase deficiency. Proc Natl Acad Sci USA 73: 2867–2871
Mills GC, Goldblum RM, Newkirk KE, Schmalstieg FC (1978) Urinary excretion of purines, purine nucleosides, and pseudouridine in adenosine deaminase deficiency. Biochem Med 20: 180–199
Milne MD, Schribner BH, Crawford MA (1958) Non-ionic diffusion and the excretion of weak acids and weak bases. Am J Med 24: 709–730
Nelson JA (1979) Applications of fluorescence detection coupled with liquid chromatography. In: Hawk GL (ed) Biological/biomedical applications of liquid chomatography. Marcell Dekker, New York, pp 397–411 (Chromatographic science. Series, vol 10)
Plaggemann PGW, Wonehueter RM (1980) Permeation of nucleosides, nucleic acid bases and nucleotides in animal cells. In: Bronner F, Kleinzeller A (eds) Current topics in membranes and transport, vol 14: Carriers and membrane transport proteins. Academic Press, New York, pp 225–230
Pollara B, Pickering RJ, Meuwissen HJ, Porter IH (eds) (1979) Inborn errors of specific immunity. Academic Press, New York
Schmalstieg FC, Kuttesch JF, Mills GC, Nelson JA, Goldman AS, Goldblum RM (1979) Metabolic effects of erythrocyte transfusions in adenosine deaminase deficiency. In: Pollara B, Pickering RJ, Meuwissen HJ, Porter IM (eds) Inborn errors of specific immunity. Academic Press, New York, pp 117–132
Seegmiller JE (1979) Abnormalities of purine metabolism in human immunodeficiency diseases. In: Baer HP, Drummond GI (eds) Physiological and regulatory functions of adenosine and adenine nucleotides. Raven Press, New York, pp 395–408
Simmonds HA, Sahota A, Potter CF, Cameron JS (1978) Purine metabolism and immunodeficiency: Urinary excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency. Clin Sci Mol Med 54: 579–584
Simmonds HA, Watson JG, Hugh-Jones K, Perrett D, Sahota A, Potter CF (1979) Deoxynucleoside excretion in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Pollara B, Pickering RJ, Mcuwissen HJ, Porter IH (eds) Inborn errors of specific immunity. Academic Press, New York, pp 377–387
Smith HW (1956) Principles of renal physiology. Oxford University Press, New York
Wistrand P, Nechay BR, Maren TH (1961) Effects of carbonic anhydrase inhibition on cerebrospinal and intraocular fluids in dog. Acta Pharmacol Toxicol (Kbh) 17: 315–336
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuttesch, J.F., Nelson, J.A. Renal handling of 2′-deoxyadenosine and adenosine in humans and mice. Cancer Chemother. Pharmacol. 8, 221–229 (1982). https://doi.org/10.1007/BF00255488
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00255488